Blood Cancer Journal

Published by: Nature Publishing Group  

People

  1. Usmani
    Usmani
  2. Dogan
    Dogan
  3. Hultcrantz
    Hultcrantz
  4. Mailankody
    Mailankody
  5. Palomba
    Palomba
  6. Giralt
    Giralt
  7. Horwitz
    Horwitz
  8. Landau
    Landau
  9. Moskowitz
    Moskowitz
  10. Shah
    Shah

Groups

  1. Department of Medicine (54)
  2. Hematologic Malignancies, Division of (52)
  3. Center for Hematologic Malignancies (48)
  4. Sloan Kettering Institute Postdocs (25)
  5. Myeloma (22)
  6. Survivorship Research (18)
  7. Department of Pathology and Laboratory Medicine (17)
  8. Hematologic Malignancies Research (17)
  9. Epidemiology and Biostatistics (16)
  10. Executive Committee, Center for Hematologic Malignancies (14)
Search Within
Formats
  1. Journal Article (50)
  2. Research Letter (15)
  3. Review (7)
  4. Correspondence (1)
  5. Guidelines (1)
Groups
  1. Department of Medicine (54)
  2. Hematologic Malignancies, Division of (52)
  3. Center for Hematologic Malignancies (48)
  4. Sloan Kettering Institute Postdocs (25)
  5. Myeloma (22)
  6. Survivorship Research (18)

More Groups

People
  1. Malin Hultcrantz (13)
  2. Saad Usmani (13)
  3. Ahmet Dogan (11)
  4. Carl Landgren (10)
  5. Maria Palomba (10)
  6. Sham Mailankody (10)

More People

Years
  1. 2025 (3)
  2. 2024 (16)
  3. 2023 (6)
  4. 2022 (11)
  5. 2021 (8)
  6. 2020 (8)

More Years

Publishers
  1. Nature Publishing Group (74)

Results (74)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A real-world experience of efficacy and safety of belantamab mafodotin in relapsed refractory multiple myeloma
    Research Letter

    Dileo, R.; Mewawalla, P.; Babu, K.; Yin, Y.; Strouse, C.; Chen, E.; Shaikh, H.; Davis, J. A.; Green, K. M.; Alkharabsheh, O.; more...
    Blood Cancer Journal (2025)

    Fulltext@MSK | Save
  • Outcomes of patients with Richter transformation who received no prior chemoimmunotherapy for their CLL
    Research Letter

    Kittai, A. S.; Huang, Y.; Miller, S.; Allan, J. N.; Bhat, S. A.; Bond, D. A.; Brander, D. M.; Byrd, J. C.; Chavez, J. C.; Chong, E.; more...
    Blood Cancer Journal (2025)

    Fulltext@MSK | Save
  • High WEE1 expression is independently linked to poor survival in multiple myeloma
    Journal Article

    Simhal, A. K.; Firestone, R. S.; Oh, J. H.; Avutu, V.; Norton, L.; Hultcrantz, M.; Usmani, S. Z.; Maclachlan, K. H.; Deasy, J. O.
    Blood Cancer Journal (2025)

    Fulltext@MSK | Save
  • Bispecific antibodies targeting BCMA or GPRC5D are highly effective in relapsed myeloma after CAR T-cell therapy
    Journal Article

    Merz, M.; Dima, D.; Hashmi, H.; Ahmed, N.; Stölzel, F.; Holderried, T. A. W.; Fenk, R.; Müller, F.; Tovar, N.; Oliver-Cáldes, A.; more...
    Blood Cancer Journal (2024)

    Fulltext@MSK | Save
  • Frontline Ph-negative B-cell precursor acute lymphoblastic leukemia treatment and the emerging role of blinatumomab
    Review

    Jabbour, E. J.; Kantarjian, H. M.; Goekbuget, N.; Shah, B. D.; Chiaretti, S.; Park, J. H.; Rijneveld, A. W.; Gore, L.; Fleming, S.; Logan, A. C.; more...
    Blood Cancer Journal (2024)

    Fulltext@MSK | Save
  • Venous thromboembolism in adolescents and young adults with acute lymphoblastic leukemia treated on a pediatric-inspired regimen
    Journal Article

    Shimony, S.; Raman, H. S.; Flamand, Y.; Keating, J.; Paolino, J. D.; Valtis, Y. K.; Place, A. E.; Silverman, L. B.; Sallan, S. E.; Vrooman, L. M.; more...
    Blood Cancer Journal (2024)

    Fulltext@MSK | Save
  • Impact of COVID-19 on outcomes with teclistamab in patients with relapsed/refractory multiple myeloma in the phase 1/2 MajesTEC-1 study
    Research Letter

    van de Donk, N. W. C. J.; Bahlis, N.; Costa, L. J.; Mateos, M. V.; Nooka, A. K.; Perrot, A.; Garfall, A. L.; Thaman, P.; Qi, K.; Uhlar, C.; more...
    Blood Cancer Journal (2024)

    Fulltext@MSK | Save
  • Evaluation of Ki-67 expression and large cell content as prognostic markers in MZL: A multicenter cohort study
    Journal Article

    Grover, N. S.; Annunzio, K.; Watkins, M.; Torka, P.; Karmali, R.; Anampa-Guzmán, A.; Oh, T. S.; Reves, H.; Tavakkoli, M.; Hansinger, E.; more...
    Blood Cancer Journal (2024)

    Fulltext@MSK | Save
  • Limited stage high grade B-cell lymphoma with MYC, BCL2 and/or BCL6 rearrangements: BCL2 rearrangements drives the poor outcomes
    Research Letter

    Lue, J. K.; Luttwak, E.; Rivas-Delgado, A.; Irawan, H.; Boardman, A.; Caron, P. C.; David, K.; Epstein-Peterson, Z.; Falchi, L.; Ghione, P.; more...
    Blood Cancer Journal (2024)

    Fulltext@MSK | Save
  • Patient preferences for intervention in the setting of precursor multiple myeloma
    Research Letter

    Marinac, C. R.; Downey, K.; Perry, J.; Fisher-Longden, B.; Rebbeck, T. R.; Shah, U. A.; O’Donnell, E. K.; Ghobrial, I. M.; Nadeem, O.; Egleston, B. L.
    Blood Cancer Journal (2024)

    Fulltext@MSK | Save

    • Blood Cancer Journal – authorized name for:

    Name ISSN / ISBN Publisher
    Blood Cancer Journal 20445385 2022, The Author(s)
    Blood Cancer Journal 20445385 The Author(s) 2023
    Blood Cancer Journal 2044-5385 Nature Publishing Group
    Blood cancer journal 20445385 Unknown
    Blood Cancer Journal 20445385 2020, The Author(s)
    Blood Cancer Journal 2044-5385 Nature Publishing Group
    Blood Cancer Journal 20445385 The Author(s) 2024
    Blood Cancer Journal 20445385 2021, The Author(s)
    Blood Cancer Journal 20445385 2019, The Author(s)
    Blood Cancer Journal 2044-5385 Nature Publishing Group
    Blood Cancer Journal 2044-5385 Nature Publishing Group
    Blood Cancer Journal 2044-5385 Springernature
    Blood Cancer Journal 2044-5385 Unknown
    Blood Cancer Journal 2044-5385 Nature Publishing Group
    Blood Cancer Journal 2044-5385 Nature Publishing Group
    Blood Cancer Journal 20445385 The Author(s) 2025
    Blood Cancer Journal 2044-5385 Macmillan Publishers Limited
    Blood Cancer Journal 20445385 Macmillan Publishers Limited
    Blood Cancer Journal 2044-5385 Nature Publishing Group
    Blood Cancer Journal 2044-5385 Nature Publishing Group
    Blood Cancer Journal 20445385 The Author(s)
    Blood Cancer Journal 20445385 2023, The Author(s)